The Valley Desk

NCT01890772 · Interventional trial

Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1

Overall registry status Withdrawn

Phase 2 · Phase 3

Conditions Hepatitis C

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov